Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society | Citedby Results | Onkologie | Karger Publishers

Skip to Main Content

Skip Nav Destination

Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society

Onkologie (1999) 22 (5): 412–415.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Randomized Phase II/III Trial of Interferon Alfa-2a With and Without 13-cis-Retinoic Acid in Patients With Progressive Metastatic Renal Cell Carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)

Nina Aass
Pieter H.M. De Mulder
Gerald H.J. Mickisch
Peter Mulders
Allan T. van Oosterom
Hein van Poppel
Sophie D. Fossa
Linda de Prijck
Richard J. Sylvester

Journal of Clinical Oncology (2005) 23 (18): 4172.

Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trials

Klaus Mross

Drug Resistance Updates (2000) 3 (4): 223.